Lei Liu

Lei Liu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in Nature Medicine
Verified
Journal Article
Closed access
MLMingfeng Liao
Mingfeng Liao
YLYang Liu
Yang Liu
JYJing Yuan
Jing Yuan
YWYanling Wen
Yanling Wen
GXGang Xu
Gang Xu
ZZZheng Zhang
Zheng Zhang

28 April 2020 in JAMA
Verified
Journal Article
Open access
PDF file
CSChenguang Shen
Chenguang Shen
ZWZhaoqin Wang
Zhaoqin Wang
FZFang Zhao
Fang Zhao
YYYang Yang
Yang Yang
JLJinxiu Li
Jinxiu Li
LLLei Liu
Lei Liu
The epidemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has rapidly spread worldwide.1 As of March 24, 2020, China had reported 81 767 cases with 3281 deaths, and the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic. As of March 18, 2020, cases were reported in approximately 195 countries.2

9 February 2020 in Science China Life Sciences
Verified
Journal Article
Open access
PDF file
YLYingxia Liu
Yingxia Liu
YYYang Yang
Yang Yang
CZCong Zhang
Cong Zhang
FHFengming Huang
Fengming Huang
FWFuxiang Wang
Fuxiang Wang
LLLei Liu
Lei Liu
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many provinces in China as well as other countries. Here we report the epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China. All 12 cases of the 2019-nCoV-infected patients developed pneumonia and half of them developed acute respiratory distress syndrome (ARDS). The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased CD8 count. The viral load of 2019-nCoV detected from patient respiratory tracts was positively linked to lung disease severity. ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity. Moreover, the Angiotensin II level in the plasma sample from 2019-nCoV infected patients was markedly elevated and linearly associated to viral load and lung injury. Our results suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker (ARB) drugs for potential repurposing treatment of 2019-nCoV infection.

12 June 2020 in Science
Verified
Journal Article
Open access
PDF file
YWYan Wu
Yan Wu
FWFeiran Wang
Feiran Wang
CSChenguang Shen
Chenguang Shen
WPWeiyu Peng
Weiyu Peng
DLDelin Li
Delin Li
LLLei Liu
Lei Liu
An antibody defense against COVID-19: One of the responses of the immune system to invading viruses is the production of antibodies. Some of these are neutralizing, meaning that they prevent the virus from being infectious, and can thus be used to treat viral diseases. Wu et al. isolated four neutralizing antibodies from a convalescent coronavirus disease 2019 (COVID-19) patient. Two of the antibodies, B38 and H4, blocked the receptor binding domain (RBD) of the viral spike protein from binding to the cellular receptor, angiotensin-converting enzyme 2 (ACE2). The structure of the RBD bound to B38 shows that the B38-binding site overlaps with the binding site for ACE2. Although H4 also blocks RBD binding to ACE2, it binds at a different site, and thus the two antibodies can bind simultaneously. This pair of antibodies could potentially be used together in clinical applications. Science , this issue p. 1274

1 September 2020 in Journal of Hepatology
Verified
Journal Article
Closed access
QCQingxian Cai
Qingxian Cai
DHDeliang Huang
Deliang Huang
HYHong Yu
Hong Yu
ZZZhibin Zhu
Zhibin Zhu
ZXZhang Xia
Zhang Xia
Lin XuLin Xu
Lin Xu

1 June 2020 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JLJiaye Liu
Jiaye Liu
XLXuejiao Liao
Xuejiao Liao
SQShen Qian
Shen Qian
JYJing Yuan
Jing Yuan
FWFuxiang Wang
Fuxiang Wang
ZZZheng Zhang
Zheng Zhang
Since early January 2020, after the outbreak of 2019 novel coronavirus infection in Wuhan, China, ≈365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed.